Engflag

Avalon (ANTIBACTERIALS)

Quick links to important sections

Avalon (ANTIBACTERIALS)

Avalon _ANTIBACTERIALS__EN

Method of action: Bactericidal, Ophthalmologicals

Treatment option: Lyme Disease, Bronchitis, Community Acquired Pneumonia, Impetigo, Infection, Infection,Soft Tissue, Middle Ear Infection, COPD,Acute, Pneumonia, Sinus Infection

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Avalon (ANTIBACTERIALS)

Avalon (ANTIBACTERIALS) is a prescription medicine and a specialized pharmaceutical preparation whose single active ingredient is Azithromycin. It is fundamentally classified as an antibacterial agent, clinically recognized for its role in addressing various diseases caused by susceptible bacterial infections.

Quick Facts about Avalon (Azithromycin)

Property Description
Active Ingredient Azithromycin
Common Forms Tablet, capsule, oral suspension, intravenous solution
Pharmacological Class Macrolide antibiotic (Azalide subclass)
General Purpose Interrupting the progression of bacterial disease
Origin Semi-synthetic compound
Manufacturer Note Produced by Avalon Pharma or related entities

What Type of Anti-infective Medicine is Avalon?

Avalon is an antibiotic that belongs to the macrolide pharmacological class, chemically categorized as a semi-synthetic azalide. This specific chemical structure, which incorporates an extra nitrogen atom into the macrolide ring, distinguishes it from older macrolides. The modification is associated with certain properties, such as a long half-life and excellent tissue penetration, allowing it to remain effective in the body for an extended period compared to some alternatives. The medicine functions exclusively as an anti-infective agent against susceptible bacteria.

Azithromycin: Composition and Available Forms

The core composition of Avalon is its active ingredient, Azithromycin, typically formulated as the dihydrate. This single-active-ingredient product is manufactured in several dosage forms to suit different patient needs, including the tablet and capsule for oral administration. Azithromycin is classified as an essential medicine due to its broad-spectrum capability and importance in treating multiple infectious diseases. It is also available as a powder for oral suspension and as a lyophilized powder for preparing an intravenous solution for parenteral administration in more severe or specialized cases.

What is the General Purpose of Avalon's Action?

The general purpose of Avalon is to interrupt the progression of bacterial disease by neutralizing the capacity of the invading microbes to multiply. This is achieved through a specific physiological action that targets the bacteria's internal machinery. The medicine is primarily known for its ability to cause the inhibition of protein synthesis within the bacterial cell, thereby stopping the bacteria from manufacturing the essential proteins required for their growth and survival. This decisive action is critical for effectively aiding the body in overcoming the bacterial infection by preventing the spread and stopping the reproduction of the infectious agent.

Regulatory References

  1. Azithromycin Drug Information
  2. Azithromycin: Clinical Pharmacology
  3. Mechanism of Action of Macrolides

What side effects are possible with Avalon (ANTIBACTERIALS)?

Possible Side Effects and Safety Information

The official safety information for Avalon highlights the risk of serious, potentially disabling, and long-lasting adverse reactions that can affect multiple body systems.

Serious and Clinically Significant Adverse Reactions

Regulatory agencies have issued strong warnings about specific serious adverse reactions. These effects can occur rapidly or up to several months after treatment is stopped.

  • Tendon and Joint Damage: Risk of tendinitis and tendon rupture (including Achilles tendon), which may occur within hours or months after taking the medicine.
  • Nervous System Effects: Potential for peripheral neuropathy (nerve damage in the arms and legs) that can be permanent, as well as central nervous system effects, including psychosis, anxiety, confusion, memory impairment, and suicidal thoughts or attempts.
  • Cardiovascular Effects: Risk of aortic aneurysm and dissection (tearing of the major artery), particularly in older patients or those with pre-existing conditions.
  • Blood Sugar Disturbances: Severe hypoglycemia (very low blood sugar) has been documented, which may lead to coma, especially in patients with diabetes.

Adverse Reactions by Frequency

Adverse reactions are officially documented by frequency:

Classification Examples of Reactions
Common (ge 1/100) Nausea, diarrhea, headache, insomnia, dizziness.
Uncommon (ge 1/1,000) Joint pain (arthralgia), muscle pain (myalgia), anxiety, nervousness, tremor.
Rare (ge 1/10,000) Tendon disorders (tendinitis), convulsions, depression, hypoglycemia.

Safety Restrictions and High-Risk Populations

Regulatory documentation restricts the use of this medicine. It must be reserved for infections where other commonly recommended antibiotics are inappropriate.

The risk of serious tendon injury is increased in certain patient groups, including those over 60 years of age, patients with kidney impairment, and those who have received organ transplants. Co-administration with corticosteroids should be avoided as it further increases the risk of tendon damage.

Overdose and Emergency Response

An overdose of Avalon (Azithromycin) is officially documented in regulatory labeling by severe manifestations that require immediate medical intervention. The observed clinical presentations typically involve an exaggeration of known adverse effects.

Documented Overdose Manifestations

Overdosage may present with severe gastrointestinal effects, including pronounced nausea, vomiting, and diarrhea. Additionally, reversible hearing loss has been reported in specific circumstances of acute, excessive exposure.

Severe and Life-Threatening Outcomes

The most critical concern noted by regulatory authorities is the potential for cardiotoxicity. Excessive exposure increases the risk of QT interval prolongation, which can lead to ventricular arrhythmias and a potentially fatal irregular heart rhythm known as Torsades de Pointes. This severe outcome is a primary factor dictating the required emergency response. Individuals with pre-existing heart conditions are noted to be particularly susceptible to these severe effects.

Mandatory Emergency Actions

The official guidance states that immediate medical attention must be sought for any suspected overdosage. Given the risk of serious cardiac events, urgent care is required when symptoms such as irregular heartbeat, profound dizziness, or fainting occur. Management is defined as symptomatic and supportive treatment, including cardiac monitoring (ECG), as no specific antidote is known. The drug’s long half-life necessitates prolonged observation.

Therapeutic Uses of Avalon (ANTIBACTERIALS)

What Avalon (ANTIBACTERIALS) Treats: Main Uses and Benefits

Avalon (Azithromycin) is commonly used in conditions presenting with systemic or localized discomfort caused by susceptible bacterial infections, and may assist with managing symptomatic episodes. The medication is utilized across several recognized therapeutic areas involving bacterial pathogens.

The medication is applied across domains where additional symptomatic support is needed, primarily helping to address respiratory and ENT infections, uncomplicated skin infections, and certain sexually transmitted infections (STIs). For instance, it is relevant in acute episodes of bacterial pneumonia, bronchitis exacerbations, sinusitis, and otitis media. The medication may assist with managing symptom clusters like persistent cough, fever, localized pain, and inflammation.

In clinical scenarios involving heightened distress, the medicine may be part of symptomatic management when symptoms create noticeable interference with daily stability. It supports the patient during difficult episodes by easing distress and contributes to easing the overall symptom load. It also helps maintain a sense of stability when symptoms are more noticeable in vulnerable populations, such as in the therapeutic settings involving supportive management for opportunistic infections.

Quick Fact: Symptomatic Support Focus
Therapeutic Areas Symptoms related to Respiratory Discomfort, Localized Inflammation, and Genital Discharge
Patient Benefit Supports easing overall symptom burden, contributes to improved day-to-day comfort
Context of Use Applied during phases when acute bacterial symptoms become more noticeable

Regulatory References

  1. European Medicines Agency (EMA) review

Eligibility and Restrictions for Use

Who can and cannot use Avalon (ANTIBACTERIALS)?

Avalon, which contains the antibiotic azithromycin (a macrolide), is prescribed to treat various bacterial infections, including those affecting the respiratory tract, middle ear, skin, and certain sexually transmitted diseases. Children over six months of age can typically use the pediatric formulation, while adults are prescribed the tablet or intravenous forms.

Contraindications and Warnings

Certain conditions or co-administered drugs make using Avalon unsafe. This medication is contraindicated in individuals with a known hypersensitivity or allergy to azithromycin or any other macrolide antibiotic. Due to the liver being the primary route of excretion for azithromycin, it should not be used in patients with hepatic disease or significant liver impairment.

Furthermore, the co-administration of ergot derivatives (used for migraines) is strictly contraindicated due to the theoretical risk of a severe circulatory condition known as ergotism.

Caution is advised for patients taking certain medications, such as digoxin or cyclosporin, as azithromycin may increase their plasma concentrations, requiring careful monitoring and potential dose adjustment. Patients with significant renal impairment typically do not require dose adjustment, but this must be assessed by a healthcare provider. Always inform your doctor of your complete medical history and all current medications.

What should I know about interactions with other medicines?

Avalon (Antibacterials) Interactions with other medicines and products

Before taking Avalon, inform your healthcare provider about all other medications, supplements, or herbal products you are taking. Certain classes of antibacterials are known to interact with other drugs, which can alter the effect of either medication or increase the risk of side effects.

Potential Drug Interactions

Interacting Drug/Product Potential Effect Recommendation/Action
Warfarin (an anticoagulant) Increased risk of bleeding (enhanced anticoagulant effect) with many antibacterials. Close monitoring of INR is essential. The dose of Warfarin may need adjustment.
Methotrexate (used for cancer/autoimmune diseases) Increased levels and toxicity of Methotrexate with some antibacterials (e.g., penicillins, tetracyclines). Careful monitoring for signs of toxicity (e.g., gastrointestinal or hematological issues).
Oral Contraceptives Decreased effectiveness of hormonal contraception, particularly with enzyme-inducing antibacterials (e.g., Rifampicin). A non-hormonal barrier method of contraception should be used during treatment and for a specified period afterward.
Antacids (containing Aluminum or Magnesium) Reduced absorption and efficacy of certain antibacterials (e.g., fluoroquinolones, tetracyclines) due to chelation. Separate the administration of the antibacterial from the antacid by at least 2 to 6 hours.

Mechanism of Action

Avalon, containing Azithromycin, works through a highly specific action that directly interferes with the core machinery responsible for bacterial life and proliferation. The drug's mechanism is defined by three key biological domains: direct target inhibition, strategic host-cell distribution, and secondary modulation of host responses.

Direct Target Inhibition of Bacterial Protein Synthesis

This mechanism involves Azithromycin seeking out and tightly binding to the 50S ribosomal subunit within susceptible bacteria, specifically at the 23S rRNA component. By occupying this site, the drug causes a physical occlusion of the nascent peptide exit tunnel, effectively preventing the ribosome from completing the protein synthesis process. This action immediately arrests the bacteria’s ability to manufacture essential proteins, resulting in the inhibition of bacterial proliferation.

Enhanced Delivery via Host Cell Accumulation

The drug exhibits a unique tendency to accumulate in high concentrations within host immune cells, such as phagocytes. These cells, which naturally migrate to sites of inflammation, act as carriers, transporting the active drug directly to the tissue. This specialized delivery mechanism contributes to high local concentrations of the active molecule at the site of microbial presence.

Secondary Modulation of Local Immune Responses

Beyond its direct antimicrobial effects, Azithromycin also influences host immune pathways. This mechanism involves a dampening of excessive inflammation by modulating the release of certain pro-inflammatory signaling molecules and limiting the over-migration of neutrophils. This action influences the localized physiological response by limiting the effects of excessive inflammation.

Dosage and Administration Information

How to Use Avalon (Azithromycin): Administration Guidelines

The administration of Avalon (Azithromycin) follows established clinical protocols. These protocols govern the route, dose, frequency, and preparation of the medicine, ensuring its standardized application in clinical practice.

Approved Administration and Dosage

Administration Route Typical Adult Dosing Regimen
Oral Multi-day: 500 mg on Day 1, followed by 250 mg daily for 4 days; OR Short-course: 500 mg once daily for 3 days; OR Single-dose: 1,000 mg or 2,000 mg for specific infections.
Intravenous (IV) 500 mg once daily for 1-2 days, followed by a switch to oral therapy.

Key Instructions for Use

Frequency and Timing

Azithromycin is administered once daily (every 24 hours). Most oral forms, such as tablets and suspension, can be taken with or without food. However, some capsule forms may require administration 1 hour before or 2 hours after a meal to optimize absorption.

Preparation and Procedure

Oral suspensions require reconstitution with a specified volume of water. The lyophilized powder for IV use must be reconstituted and diluted to a final concentration before administration. The IV solution must be infused slowly over a minimum of 60 minutes; it must not be given as a bolus or intramuscular injection.

Population-Specific Guidance

Generally, no dose adjustment is required for older adult patients or those with mild to moderate renal or hepatic impairment. Caution is recommended in severe impairment as systemic exposure may be increased.

Recent Clinical Evidence

Recent Clinical Evidence Overview

Clinical research and observational studies related to antibacterial agents marketed under the name Avalon focus primarily on demonstrating activity against susceptible bacterial strains. The specific agent often referenced, which is a macrolide-class antibiotic (azithromycin), is indicated for a range of infections, including those of the respiratory tract, middle ear (otitis media), skin and soft tissues, and certain sexually transmitted infections.

Established Indications and Spectrum

Evidence supports the use of this antibiotic for infections caused by susceptible organisms, such as Chlamydia trachomatis, Haemophilus influenzae, and Moraxella catarrhalis. This includes established efficacy in treating conditions such as community-acquired pneumonia and non-gonococcal urethritis/cervicitis.

Studies evaluating macrolides like azithromycin have explored potential non-antibiotic properties, particularly anti-inflammatory and immunomodulatory effects, which have been investigated in chronic conditions like chronic obstructive pulmonary disease (COPD). Research suggests that for some patients with stable COPD, long-term, low-dose use may affect the frequency of exacerbations, though such decisions require careful clinical review due to the potential for antibiotic resistance and other safety concerns.

Emerging Research Areas

Ongoing research continues to investigate the clinical role of this class of antibiotics. One area of focus involves the use of related gold-based compounds (Auranofin and derivatives), which have been studied in in vitro and animal models for potential antimicrobial and antibiofilm activity against drug-resistant Gram-positive bacteria, such as Staphylococcus aureus and Staphylococcus epidermidis associated with biofilm-related infections. These findings are preliminary and require translation into human clinical trials before any definitive therapeutic claims can be made.

Frequently Asked Questions (FAQ)

Common questions about Avalon (ANTIBACTERIALS) (FAQ)

Q: What is Avalon (ANTIBACTERIALS) used for?

Regulatory documents state that Avalon is used to treat a range of bacterial infections. It is prescribed for infections such as acute bacterial sinusitis, community-acquired pneumonia, and complicated skin and soft tissue infections. Official product information indicates its use against specific types of bacteria that are known to be susceptible to this medicine.

Q: How long will I need to take Avalon (ANTIBACTERIALS)?

According to the official product information, the duration of treatment with Avalon depends on the type and severity of the infection being treated. For example, a treatment course for an acute infection may be 5–7 days, while more complex infections may require a longer course. The length of treatment is ultimately determined by the prescribing healthcare professional.

Q: Can I take Avalon (ANTIBACTERIALS) with food?

Official information indicates that Avalon tablets can be taken either with or without food. The method of administration is flexible. The official documentation emphasizes taking the medicine consistently, as directed by the prescriber. If there is uncertainty, one can refer to the patient information leaflet that comes with the medicine.

Q: What should I do if I miss a dose of Avalon (ANTIBACTERIALS)?

According to the official product information, if a dose of Avalon is forgotten, the product information states that an individual may take the missed dose as soon as it is remembered, unless it is almost time for the next dose. If it is close to the next scheduled dose, the individual should skip the missed dose and continue with the regular schedule. Regulatory warnings advise against taking a double dose to compensate for a missed dose.

Q: Does Avalon (ANTIBACTERIALS) cause sun sensitivity?

Regulatory documents and official product information for Avalon indicate that this medicine can make the skin more sensitive to sunlight, a condition known as photosensitivity. Because of this, it is advised to avoid direct sunlight and sunlamps while taking Avalon and for a period after treatment ends. Regulatory documents recommend taking protective measures, such as using protective clothing and appropriate sunscreens.

Q: What is the active ingredient in Avalon (ANTIBACTERIALS)?

The active ingredient responsible for the antibacterial action in Avalon is a substance called Levofloxacin. This component is classified as a fluoroquinolone antimicrobial agent. Official information confirms that it works by stopping the growth of certain bacteria, thus treating the infection.

How should Avalon (ANTIBACTERIALS) be stored and disposed of?

How to Store and Dispose of Avalon (ANTIBACTERIALS)?

Official regulatory information defines specific environmental and stability requirements for Avalon (Azithromycin) and its disposal.

Official Storage Requirements

Item Mandatory Conditions
Temperature Azithromycin tablets and dry powder for suspension require storage at or below 30^circC (FDA). Tablets specifically require 15^circC to 30^circC (FDA).
Protection Keep the product in a tightly closed container, away from excess heat and moisture (NIH).
Child Safety All forms of the medicine must be kept out of the sight and reach of children (NIH).
Stability The multi-dose oral suspension must be discarded 10 days after it is constituted (NIH). The constituted extended-release suspension must not be refrigerated (NIH).

Official Disposal Instructions

Discard any unused or expired Azithromycin according to official guidelines. Medicines not listed for flushing should be mixed with an undesirable substance, such as dirt or used coffee grounds, placed in a sealed bag or container, and thrown away in the household trash (FDA Disposal Guidance).

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

flagBangladesh

Equivalent of Avalon (ANTIBACTERIALS) found in:

A-Z Index: